STRS Ohio’s ADMA Biologics ADMA Stock Holding History

STRS Ohio’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$741K	Buy	88,500 +62,400	+239%	+$569K	﹤0.01%	892
2026 Q1	$235K	Sell	26,100 -32,800	-56%	-$518K	﹤0.01%	1423
2025 Q4	$1.07M	Sell	58,900 -10,300	-15%	-$174K	﹤0.01%	682
2025 Q3	$1.01M	Hold	69,200	–	–	﹤0.01%	676
2025 Q2	$1.26M	Buy	69,200 +3,300	+5%	+$67.3K	﹤0.01%	835
2025 Q1	$1.31M	Sell	65,900 -3,700	-5%	-$64K	0.01%	756
2024 Q4	$1.19M	Buy	69,600 +3,200	+5%	+$60.2K	﹤0.01%	804
2024 Q3	$1.33M	Sell	66,400 -16,100	-20%	-$250K	0.01%	813
2024 Q2	$922K	Sell	82,500 -29,500	-26%	-$247K	﹤0.01%	904
2024 Q1	$739K	Buy	112,000 +60,600	+118%	+$331K	﹤0.01%	1024
2023 Q4	$232K	Hold	51,400	–	–	﹤0.01%	1518
2023 Q3	$184K	Buy	51,400 +20,900	+69%	+$80.4K	﹤0.01%	1583
2023 Q2	$112K	Buy	+30,500	New	+$113K	﹤0.01%	1707
2021 Q2	–	Sell	-400	Closed	–	–	2223
2021 Q1	$0	Hold	400	–	–	﹤0.01%	2167
2020 Q4	$0	Hold	400	–	–	﹤0.01%	2153
2020 Q3	$0	Hold	400	–	–	﹤0.01%	2181
2020 Q2	$1K	Hold	400	–	–	﹤0.01%	2143
2020 Q1	$1K	Hold	400	–	–	﹤0.01%	2003
2019 Q4	$1K	Hold	400	–	–	﹤0.01%	2045
2019 Q3	$1K	Hold	400	–	–	﹤0.01%	2062
2019 Q2	$1K	Hold	400	–	–	﹤0.01%	2099
2019 Q1	$1K	Hold	400	–	–	﹤0.01%	2042
2018 Q4	$0	Sell	400 -5,100	-93%	-$25.3K	﹤0.01%	2068
2018 Q3	$34K	Hold	5,500	–	–	﹤0.01%	1989
2018 Q2	$24K	Buy	+5,500	New	+$27.4K	﹤0.01%	2047

Other funds holding ADMA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

STRS Ohio's ADMA Position: Q2 2026 in Review

STRS Ohio increased its ADMA Biologics (ADMA) stake by 239% in Q2 2026, buying an estimated $569K and bringing the position to 88,500 shares worth $741K. The position accounts for ﹤0.01% of the portfolio, ranked #892.

STRS Ohio first reported a position in ADMA in Q2 2018 and has held it in 25 quarters since. The position peaked at $1.33M in Q3 2024. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

STRS Ohio held 88,500 shares of ADMA Biologics worth $741K as of Q2 2026.
STRS Ohio bought 62,400 ADMA Biologics shares in Q2 2026, an estimated $569K.
ADMA Biologics made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #892 holding.
STRS Ohio first reported a position in ADMA Biologics in Q2 2018 and has held it in 25 quarters since.
STRS Ohio's ADMA Biologics position peaked at $1.33M in Q3 2024.
323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.